Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Overweight/obesity among adult survivors of childhood
SCT
has been considered to be predictive of eventual development of metabolic abnormalities.
Fatty liver
is increasingly recognized as a major cause of liver-related morbidity and mortality in the general population. However, the real incidence of
fatty liver
in adult survivors of
SCT
has not been fully elucidated. We determined whether adult survivors are at risk for overweight/obesity, metabolic abnormalities and
fatty liver
and whether these risks are associated with cranial radiotherapy (CRT) before
SCT
. Among the 51 patients (30 males), only two male patients were overweight/obese at the last evaluation. On the other hand, 9 male (30%) and 15 female (71%) patients were underweight.
Fatty liver
was diagnosed in 11 male (37%) and 10 female (48%) patients during the follow-up period, although patients who had
fatty liver
did not tend to be overweight/obese. Significantly more patients who received CRT before
SCT
developed
fatty liver
with insulin resistance than those who did not (P<0.05). Even patients who are not overweight/obese may develop
fatty liver
and metabolic abnormalities. We recommend that healthcare professionals recognize these risks and give life-long attention to detecting, preventing and treating late complications after
SCT
.
...
PMID:High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT. 2056 24